Xarelto belongs to a class of blood thinners known as direct thrombin inhibitors, which also includes Pradaxa and Eliquis. The medication was developed by Bayer Healthcare and Johnson & Johnson’s Janssen Pharmaceuticals unit, and was initially approved for sale by the U.S. Food & Drug Administration (FDA) in 2011.
Blood thinners like Xarelto are used to prevent dangerous blood clots, such as deep vein thrombosis and pulmonary embolism. Specifically, Xarelto is prescribed to prevent such clots in patients who suffer from atrial fibrillation, as well as in people who have undergone hip and knee replacement surgery. Finally, Xarelto is also indicated to treat deep vein thrombosis and pulmonary embolism.
Like any blood thinner, Xarelto can cause some patients to experience dangerous episodes of internal bleeding. However, there is currently no approved antidote to reverse Xarelto internal bleeding. As a result, even a minor trauma that causes hemorrhaging – such as a seemingly-minor hit to the head – can result in a life-threatening health crisis for a Xarelto patient. By contrast, bleeding associated with an older drug called warfarin can be stopped via the administration of Vitamin K. Xarelto bleeding can include:
Symptoms of this potential Xarelto complication may include:
Xarelto deep vein thrombosis is a blood clot that occurs deep in the veins, usually the legs, in patients who use the medication. While Xarelto is approved to prevent and even treat blood clots, a study published by the Institute for Safe Medicine Practice (ISMP) in 2013 revealed that 158 cases of Xarelto blood clots were reported to the FDA during the first quarter of 2012. These included a number of deep vein thrombosis cases.
Xarelto patients should contact their doctor if they experience:
In its October 2013 report, the ISMP also revealed that pulmonary embolism was one of the most common blood-clot related problems reported in association with Xarelto. A pulmonary embolism is a sudden blockage of a lung artery by a blood clot- usually a deep vein thrombosis – that has traveled from the leg. These dangerous clots can result in death if they are large, or if a victim experiences more than one.
Plaintiffs who have filed a Xarelto lawsuit accuse the drug’s manufacturers of failing to provide adequate warnings about its risks, and of downplaying these dangers in marketing materials for the medication. Plaintiffs also allege that Xarelto was wrongly marketed as a superior alternative to warfarin, especially in light of the fact that no approved reversal agent exits for Xarelto bleeding.
If the allegations in these lawsuits are proven true, victims of Xarelto complications may be entitled to compensation for all of their injury-related damages, including:
As soon as possible. Product liability claims like those involving Xarelto are subject to statutes of limitations that set strict deadlines for filing a case. A Xarelto lawyer will be able to research your state’s statute of limitations to ensure that your lawsuit is filed in a timely manner.
A Xarelto class action would require you to join one lawsuit that involves potentially hundreds of plaintiffs. Class members in these types of claims usually have sustained very similar injuries and damages. By contrast, filing an individual lawsuit allows each plaintiff’s case to be evaluated on its individual merits, and any recovery would be tailored to the specific damages incurred.
The Xarelto lawyers at Bernstein Liebhard LLP are actively filing claims on behalf of individuals who were allegedly harmed by this medication, so they possess a deep understanding of the issues involved in these cases. Since 1993, our Firm has helped hundreds of people harmed by dangerous drugs and other consumer products, and we’ve recovered more than $3 billion for our clients.
Bernstein Liebhard LLP is now offering free, no obligation legal consultations to alleged victims of Xarelto bleeding and other complications. Our attorneys will evaluate your case, and determine if you might be eligible to file a claim. They will also fully explain the process for filing a Xarelto lawsuit so that you can make the best decision for you and your family.
Because Bernstein Liebhard LLP is representing Xarelto lawsuit plaintiffs on a contingency basis, you will not initially be expected to pay any attorney’s fees or expenses. In fact, such fees will only be assessed if our Firm obtains a recovery on your behalf, and they will be taken directly from your settlement or award. The percentage of your recovery earmarked for fees and expenses, as well as other details of the contingency fee arrangement, will be fully spelled out in the retainer agreement you sign with our Firm. And of course, your Xarelto attorney will be able to answer any other questions you might have.
Of Course! Our attorneys represent clients in all 50 states. We would be glad to discuss your Xarelto case with you.